Menu

Solventum Corporation SOLV

Full chart Compare
Set alert

Price alert · SOLV

All alert types
90.38 USD +3.20 (+3.67%)

At closeNov 6, 2026, 4:05 PM EST

90.38 0.00 0.00%

After hours · Nov 6, 4:05 PM ET

85.05 Day range 93.00
62.38 52-week range 94.16
YTD
+14.06%
1 year
+36.36%
Market cap
15.38B
Revenue (ttm)
8.16B
Profit margin
1.91%
EPS (ttm)
0.89
Shares out
170.22M
P/E ratio
101.55
Forward P/E
12.43
YTD return
+14.06%
1-year return
+36.36%
Volume
3.17M
Avg volume
1.03M
Open
86.45
Previous close
87.18
Day's range
85.05 – 93.00
52-week range
62.38 – 94.16
Analysts
Buy
Price target
94.69 (+4.8%)
Earnings date
Feb 25, 2027

5D +8.11 (+9.86%)

8590MonTueWedThuFri90.38

Key statistics

Enterprise value
19.64B
PEG ratio
1.22
Price / sales
1.88
Price / book
3.20
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-7.00%
Free cash flow
165.38M
Total cash
451.00M
Total debt
5.27B
Return on equity
3.19%
Short % of float
3.43%
50-day average
87.74
200-day average
78.50

Financials — quick view

All financials
SOLV Revenue — quarterly 2.21B
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV Net income — quarterly 92.00M
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV EPS — quarterly 0.53
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SOLV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Dec 30, 20261.77———
Nov 5, 2026Sep 30, 20261.341.45+0.11+8.21%
Aug 5, 2026Jun 30, 20261.902.55+0.65+34.21%
May 5, 2026Mar 31, 20261.351.48+0.13+9.63%
Feb 26, 2026Dec 31, 20251.501.57+0.07+4.67%
Nov 6, 2025Sep 30, 20251.431.50+0.07+4.90%

Upgrades / downgrades

SOLV analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026Wells FargomainEqual-WeightEqual-Weight
Nov 6, 2026Piper SandlerreitOverweightOverweight
Sep 14, 2026BTIGreitBuyBuy
Aug 6, 2026UBSmainBuyBuy
Aug 6, 2026Piper SandlermainOverweightOverweight
Aug 6, 2026WedbushmainOutperformOutperform

About Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on SOLV — it syncs with the Stock Master app.

Insider holders

SOLV insider holders
InsiderRelationLatest transactionDateShares held
3M COBeneficial Owner of more than 10% of a Class of SecuritySaleAug 14, 202525,569,200
COX CARRIE SMITHDirectorConversion of Exercise of derivative securityApr 29, 202616,400
GOMEZ TAMMY LOfficerConversion of Exercise of derivative securityMay 12, 202613,362
HANSON BRYAN CRAIGChief Executive OfficerConversion of Exercise of derivative securityAug 31, 2026185,515
HARRINGTON PAUL SOfficerConversion of Exercise of derivative securityMay 12, 202620,452
KIRBERGER MARCELA A.OfficerConversion of Exercise of derivative securityMay 12, 202613,540

Institution ownership

SOLV institution ownership
Holder% heldSharesValueReported
Independent Franchise Partners, LLP9.50%16,170,0381.46BJun 29, 2026
Blackrock Inc.5.73%9,761,863881.79MJun 29, 2026
Vanguard Capital Management LLC5.65%9,624,829869.41MJun 29, 2026
Trian Fund Management, LP4.84%8,236,753744.03MJun 29, 2026
Vanguard Portfolio Management LLC3.72%6,328,641571.67MJun 29, 2026
Davis Selected Advisers3.71%6,307,729569.78MJun 29, 2026

Fund ownership

SOLV fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.75%4,674,934422.29MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.24%3,816,022344.70MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.98%3,375,087304.87MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.40%2,385,590215.49MSep 29, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF1.28%2,172,808196.27MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.26%2,138,463193.17MJun 29, 2026